ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : National Institutes of Health : National Institute on Drug Abuse (NIDA)


Include trials that are no longer recruiting patients.

262 studies were found. Here are studies 1 to 50.
1.Recruiting4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Condition: HIV Infections
2.CompletedActivity Monitoring Assessment of Opiate Withdrawal - 4
3.CompletedAcute Withdrawal from Smoked Cocaine - 9
Conditions: Cocaine-Related Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders
4.CompletedAlterations in Serotonergic Functions in Cocaine Addicts - 1
Condition: Cocaine-Related Disorders
5.CompletedAlternate Day Buprenorphine Administration, Phase IX - 14
Condition: Opioid-Related Disorders
6.CompletedAlternate Day Buprenorphine Administration, Phase X - 15
Condition: Opioid-Related Disorders
7.CompletedAlternate Day Buprenorphine Administration, Phase XI - 16
Condition: Opioid-Related Disorders
8.CompletedAlternate Day Buprenorphine Administration, Phase XII - 17
Condition: Opioid-Related Disorders
9.CompletedAlternate-Day Buprenorphine Administration. Phase I - 3
Condition: Opioid-Related Disorders
10.CompletedAlternate-Day Buprenorphine Administration. Phase II - 4
Condition: Opioid-Related Disorders
11.CompletedAlternate-Day Buprenorphine Administration. Phase IV - 5
Condition: Opioid-Related Disorders
12.CompletedAlternate-Day Buprenorphine Administration. Phase VI - 7
Condition: Opioid-Related Disorders
13.CompletedAlternate-Day Buprenorphine Administration. Phase VII - 8
Condition: Opioid-Related Disorders
14.CompletedAlternate-Day Buprenorphine Administration. Phase VIII - 9
Condition: Opioid-Related Disorders
15.CompletedAlternate-Day Buprenorphine. Phase V - 6
Condition: Opioid-Related Disorders
16.CompletedAmphetamine Cocaine Interaction Study - 2
Condition: Cocaine-Related Disorders
17.No longer recruitingAntibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission
Condition: HIV Infections
18.RecruitingAssessment of Interactions between Methamphetamine and Aripiprazole - 1
Condition: Amphetamine-Related Disorders
19.RecruitingAssessment of Potential Interactions between Cocaine and RPR 102681 - 1
Condition: Cocaine-Related Disorders
20.No longer recruitingAssessment of Potential Interactions between Cocaine and Tolcapone - 1
Condition: Cocaine-Related Disorders
21.No longer recruitingAssessment of Potential Interactions between Methamphetamine and Bupropion - 1
Condition: Amphetamine-Related Disorders
22.No longer recruitingAssessment of Potential Interactions between Methamphetamine and Selegiline - 1
Condition: Amphetamine-Related Disorders
23.RecruitingAssessment of the Potential Interactions between Cocaine and GBR 12909 - 1
Condition: Cocaine-Related Disorders
24.RecruitingBaclofen for the Treatment of Cocaine Dependence - 1
Condition: Cocaine-Related Disorders
25.No longer recruitingA behavioral trial for the treatment of methamphetamine dependence. - 1
Condition: Substance-Related Disorders
26.No longer recruitingBrain Changes in Stimulant Dependent Subjects - 8
Condition: Substance-Related Disorders
27.CompletedBrain Imaging: Cocaine Effects & Medication Development - 5
Condition: Cocaine-Related Disorders
28.RecruitingBrief Strategic Family Therapy for Adolescent Drug Abusers - 1
Condition: Behavior Therapy
29.Not yet recruitingBufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women
Conditions: HIV Infections; HIV Seronegativity
30.CompletedBuprenorphine and Naloxone Combination Study - 10
Conditions: Heroin Dependence; Opioid-Related Disorders
31.CompletedBuprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
Conditions: Heroin Dependence; Substance-Related Disorders
32.CompletedBuprenorphine Combination Tablet Feasibility - 1
Condition: Opioid-Related Disorders
33.CompletedBuprenorphine Detox with Two Types of Treatment. BBD I - 10
Condition: Opioid-Related Disorders
34.CompletedBuprenorphine Detox with Two Types of Treatment. BBD II - 11
Condition: Opioid-Related Disorders
35.CompletedBuprenorphine Detoxification - BBDVI - 19
Condition: Opioid-Related Disorders
36.CompletedBuprenorphine Detoxification with Two Types of Treatment. BBD III - 12
Condition: Opioid-Related Disorders
37.CompletedBuprenorphine Detoxification with Two Types of Treatment. BBD IV - 13
Condition: Opioid-Related Disorders
38.CompletedBuprenorphine Dose Alteration Study - 1
Condition: Opioid-Related Disorders
39.CompletedBuprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2
Conditions: Opioid-Related Disorders; Substance-Related Disorders
40.CompletedBuprenorphine Dosing Interval - 5
Condition: Opioid-Related Disorders
41.No longer recruitingBuprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
Condition: Opioid-Related Disorders
42.No longer recruitingBuprenorphine Maintenance Dose Schedule and Treatment Setting - 1
Conditions: Opioid-Related Disorders; Substance-Related Disorders
43.CompletedBuprenorphine Maintenance Dose Schedule and Treatment Setting - 2
Conditions: Opioid-Related Disorders; Substance-Related Disorders
44.CompletedBuprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
Conditions: Cocaine-Related Disorders; Opioid-Related Disorders; Substance-Related Disorders
45.CompletedBuprenorphine Maintenance for Opiate Dependence - 6
Conditions: Opioid-Related Disorders; Substance-Related Disorders
46.CompletedBuprenorphine Maintenance for Opioid Addicts - 1
Condition: Opioid-Related Disorders
47.CompletedBuprenorphine Maintenance for Opioid Addicts - 2
Condition: Opioid-Related Disorders
48.CompletedBuprenorphine Maintenance for Opioid Addicts - 3
Condition: Opioid-Related Disorders
49.CompletedBuprenorphine Maintenance Protocol - 1
Condition: Opioid-Related Disorders
50.CompletedBuprenorphine Pharmacology Related to Addiction Treatment - 18
Condition: Opioid-Related Disorders

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act